Xcout Intel
BioCurie, Inc.
BioCurie, Inc. is a biotechnology company developing artificial intelligence solutions for the life sciences and pharmaceutical industries.
Subscribe to see BioCurie, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BioCurie, Inc. at a glance
BioCurie, Inc. is a company headquartered in United States. Its most recent funding round raised $500,000 in June 2025. Xcout tracks 9 named people at BioCurie, Inc., including Irene Rombel (CEO).
BioCurie, Inc. leadership
- Irene RombelCEO
- Irene RombleExecutive Officer
- Jessica D FedererDirector
- Jessica FedererDirector
- Li ShenDirector
- Richard D BraatzDirector
3 more named people on record for BioCurie, Inc., with roles, board committees and tenure — see the full roster →
BioCurie, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $500,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
BioCurie, Inc. competitors
A few of BioCurie, Inc.'s closest competitors — see the full list of competitors and alternatives →
Quris AI is a biotechnology research company headquartered in Boston, Massachusetts, that uses machine learning and biosensing platforms to predict clinical safety and drug efficacy.
Accutar Biotechnology, Inc. is a U.S.-based biotechnology company located in Brooklyn, New York, that focuses on artificial intelligence-empowered drug discovery.
Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.
OneThree Biotech, Inc. is a biotechnology and health technology company utilizing machine learning and AI models for drug target discovery and pharmaceutical optimization, based in Astoria, New York.
PostEra Inc. is a U.S.-based biotechnology company that develops machine-learning and computational chemistry software for drug discovery and medicinal chemistry. Its platform helps pharmaceutical and biotechnology organizations design, prioritize, and manage experiments for small-molecule therapeutics.
Get BioCurie, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on BioCurie, Inc. in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access